ReP USP - Resultado da busca

Artigo de periodico
Global Surgery 2030: evidence and solutions for achieving health, welfare, and economic development (2015)
Meara, John G.; Leather, Andrew J. M.; Hagander, Lars; Alkire, Blake C.; Alonso, Nivaldo; Ameh, Emmanuel A.; Bickler, Stephen W.; Conteh, Lesong; Dare, Anna J.; Davies, Justine; Mérisier, Eunice Dérivois; El-Halabi, Shenaaz; Farmer, Paul E.; Gawande, Atul; Gillies, Rowan; Greenberg, Sarah L. M.; Grimes, Caris E.; Gruen, Russell L.; Ismail, Edna Adan; Kamara, Thaim Buya; Lavy, Chris; Lundeg, Ganbold; Mkandawire, Nyengo C.; Raykar, Nakul P.; Riesel, Johanna N.; Rodas, Edgar; Rose, John; Roy, Nobhojit; Shrime, Mark G.; Sullivan, Richard; Verguet, Stéphane; Watters, David; Weiser, Thomas G.; Wilson, Iain H.; Yamey, Gavin; Yip, Winnie
Source: Lancet. Unidade: FM
Subjects: ASSISTÊNCIA À SAÚDE, SAÚDE PÚBLICA, CIRURGIA (CONDIÇÕES ECONÔMICAS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MEARA, John G. et al. Global Surgery 2030: evidence and solutions for achieving health, welfare, and economic development. Lancet, v. 386, n. 9993, p. 569-624, 2015Tradução . . Disponível em: https://doi.org/10.1016/S0140-6736(15)60160-X. Acesso em: 08 nov. 2024.
APA
Meara, J. G., Leather, A. J. M., Hagander, L., Alkire, B. C., Alonso, N., Ameh, E. A., et al. (2015). Global Surgery 2030: evidence and solutions for achieving health, welfare, and economic development. Lancet, 386( 9993), 569-624. doi:10.1016/S0140-6736(15)60160-X
NLM
Meara JG, Leather AJM, Hagander L, Alkire BC, Alonso N, Ameh EA, Bickler SW, Conteh L, Dare AJ, Davies J, Mérisier ED, El-Halabi S, Farmer PE, Gawande A, Gillies R, Greenberg SLM, Grimes CE, Gruen RL, Ismail EA, Kamara TB, Lavy C, Lundeg G, Mkandawire NC, Raykar NP, Riesel JN, Rodas E, Rose J, Roy N, Shrime MG, Sullivan R, Verguet S, Watters D, Weiser TG, Wilson IH, Yamey G, Yip W. Global Surgery 2030: evidence and solutions for achieving health, welfare, and economic development [Internet]. Lancet. 2015 ; 386( 9993): 569-624.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/S0140-6736(15)60160-X
Vancouver
Meara JG, Leather AJM, Hagander L, Alkire BC, Alonso N, Ameh EA, Bickler SW, Conteh L, Dare AJ, Davies J, Mérisier ED, El-Halabi S, Farmer PE, Gawande A, Gillies R, Greenberg SLM, Grimes CE, Gruen RL, Ismail EA, Kamara TB, Lavy C, Lundeg G, Mkandawire NC, Raykar NP, Riesel JN, Rodas E, Rose J, Roy N, Shrime MG, Sullivan R, Verguet S, Watters D, Weiser TG, Wilson IH, Yamey G, Yip W. Global Surgery 2030: evidence and solutions for achieving health, welfare, and economic development [Internet]. Lancet. 2015 ; 386( 9993): 569-624.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/S0140-6736(15)60160-X
Artigo de periodico
Mortality risk attributable to high and low ambient temperature: a multicountry observational study (2015)
Gasparrini, Antonio; Guo, Yuming; Hashizume, Masahiro; Lavigne, Eric; Zanobetti, Antonella; Schwartz, Joel; Tobias, Aurelio; Tong, Shilu; Rocklöv, Joacim; Forsberg, Bertil; Leone, Michela; De Sario, Manuela; Bell, Michelle L.; Guo, Yue-Liang Leon; Wu, Chang-fu; Kan, Haidong; Yi, Seung-Muk; Coelho, Micheline de Sousa Zanotti Stagliorio; Saldiva, Paulo Hilário Nascimento ; Honda, Yasushi; Kim, Ho; Armstrong, Ben
Source: Lancet. Unidade: FM
Subjects: MORTALIDADE, TEMPERATURA AMBIENTE, EXPOSIÇÃO AMBIENTAL, FATORES DE RISCO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GASPARRINI, Antonio et al. Mortality risk attributable to high and low ambient temperature: a multicountry observational study. Lancet, v. 386, n. 9991, p. 369-375, 2015Tradução . . Disponível em: https://doi.org/10.1016/S0140-6736(14)62114-0. Acesso em: 08 nov. 2024.
APA
Gasparrini, A., Guo, Y., Hashizume, M., Lavigne, E., Zanobetti, A., Schwartz, J., et al. (2015). Mortality risk attributable to high and low ambient temperature: a multicountry observational study. Lancet, 386( 9991), 369-375. doi:10.1016/S0140-6736(14)62114-0
NLM
Gasparrini A, Guo Y, Hashizume M, Lavigne E, Zanobetti A, Schwartz J, Tobias A, Tong S, Rocklöv J, Forsberg B, Leone M, De Sario M, Bell ML, Guo Y-LL, Wu C-fu, Kan H, Yi S-M, Coelho M de SZS, Saldiva PHN, Honda Y, Kim H, Armstrong B. Mortality risk attributable to high and low ambient temperature: a multicountry observational study [Internet]. Lancet. 2015 ; 386( 9991): 369-375.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/S0140-6736(14)62114-0
Vancouver
Gasparrini A, Guo Y, Hashizume M, Lavigne E, Zanobetti A, Schwartz J, Tobias A, Tong S, Rocklöv J, Forsberg B, Leone M, De Sario M, Bell ML, Guo Y-LL, Wu C-fu, Kan H, Yi S-M, Coelho M de SZS, Saldiva PHN, Honda Y, Kim H, Armstrong B. Mortality risk attributable to high and low ambient temperature: a multicountry observational study [Internet]. Lancet. 2015 ; 386( 9991): 369-375.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/S0140-6736(14)62114-0
Artigo de periodico-dep/entr
Familial hypercholesterolaemia: PCSK9 inhibitors are coming [comentário] (2015)
Santos, Raul D.; Watts, Gerald F.
Source: Lancet. Unidade: FM
Subjects: FATORES DE RISCO, MUTAÇÃO GENÉTICA, DOENÇAS CARDIOVASCULARES (ETIOLOGIA), HIPERCOLESTEROLEMIA (COMPLICAÇÕES)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Raul D. e WATTS, Gerald F. Familial hypercholesterolaemia: PCSK9 inhibitors are coming [comentário]. Lancet. London: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/S0140-6736(14)61702-5. Acesso em: 08 nov. 2024. , 2015
APA
Santos, R. D., & Watts, G. F. (2015). Familial hypercholesterolaemia: PCSK9 inhibitors are coming [comentário]. Lancet. London: Faculdade de Medicina, Universidade de São Paulo. doi:10.1016/S0140-6736(14)61702-5
NLM
Santos RD, Watts GF. Familial hypercholesterolaemia: PCSK9 inhibitors are coming [comentário] [Internet]. Lancet. 2015 ; 385( 9965): 307-310.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/S0140-6736(14)61702-5
Vancouver
Santos RD, Watts GF. Familial hypercholesterolaemia: PCSK9 inhibitors are coming [comentário] [Internet]. Lancet. 2015 ; 385( 9965): 307-310.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/S0140-6736(14)61702-5
Artigo de periodico
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 (2015)
Forouzanfar, Mohammad H.; Lotufo, Paulo A.; Polanczyk, Guilherme V.
Source: Lancet. Unidade: FM
Subjects: FATORES DE RISCO, EXPOSIÇÃO OCUPACIONAL, PREVENÇÃO DE DOENÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FOROUZANFAR, Mohammad H. e LOTUFO, Paulo A. e POLANCZYK, Guilherme V. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet, v. 386, n. 10010, p. 2287-2323, 2015Tradução . . Disponível em: http://www.sciencedirect.com/science/article/pii/S0140673615001282. Acesso em: 08 nov. 2024.
APA
Forouzanfar, M. H., Lotufo, P. A., & Polanczyk, G. V. (2015). Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet, 386( 10010), 2287-2323. doi:10.1016/s0140-6736(16)31679-8
NLM
Forouzanfar MH, Lotufo PA, Polanczyk GV. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 [Internet]. Lancet. 2015 ; 386( 10010): 2287-2323.[citado 2024 nov. 08 ] Available from: http://www.sciencedirect.com/science/article/pii/S0140673615001282
Vancouver
Forouzanfar MH, Lotufo PA, Polanczyk GV. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 [Internet]. Lancet. 2015 ; 386( 10010): 2287-2323.[citado 2024 nov. 08 ] Available from: http://www.sciencedirect.com/science/article/pii/S0140673615001282
Artigo de periodico
Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 (2015)
Naghavi, Mohsen; Lotufo, Paulo A.
Source: Lancet. Unidade: FM
Subjects: CAUSA DA MORTE (ANÁLISE), POLÍTICA DE SAÚDE, EPIDEMIOLOGIA, ESTIMATIVA DE POPULAÇÃO, MORTALIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NAGHAVI, Mohsen e LOTUFO, Paulo A. Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet, v. 385, n. 9963, p. 117-171, 2015Tradução . . Disponível em: https://doi.org/10.1016/S0140-6736(14)61682-2. Acesso em: 08 nov. 2024.
APA
Naghavi, M., & Lotufo, P. A. (2015). Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet, 385( 9963), 117-171. doi:10.1016/S0140-6736(14)61682-2
NLM
Naghavi M, Lotufo PA. Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 [Internet]. Lancet. 2015 ; 385( 9963): 117-171.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/S0140-6736(14)61682-2
Vancouver
Naghavi M, Lotufo PA. Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 [Internet]. Lancet. 2015 ; 385( 9963): 117-171.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/S0140-6736(14)61682-2
Artigo de periodico
International Society of Nephrology's 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology (2015)
Mehta, Ravindra L.; Cerdá, Jorge; Burdmann, Emmanuel A.; Tonelli, Marcello; García-García, Guillermo; Jha, Vivekanand; Susantitaphong, Paweena; Rocco, Michael; Vanholder, Raymond; Sever, Mehmet Sukru; Cruz, Dinna; Jaber, Bertrand; Lameire, Norbert H.; Lombardi, Raúl; Lewington, Andrew; Feehally, John; Finkelstein, Fredric; Levin, Nathan; Pannu, Neesh
Source: Lancet. Unidade: FM
Subjects: COLESTEROL, CORONARIOPATIA, HIPERCOLESTEROLEMIA, LIPOPROTEÍNAS LDL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MEHTA, Ravindra L. et al. International Society of Nephrology's 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology. Lancet, v. 385, n. 9987, p. 2616-2643, 2015Tradução . . Disponível em: https://doi.org/10.1016/S0140-6736(15)60126-X. Acesso em: 08 nov. 2024.
APA
Mehta, R. L., Cerdá, J., Burdmann, E. A., Tonelli, M., García-García, G., Jha, V., et al. (2015). International Society of Nephrology's 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology. Lancet, 385( 9987), 2616-2643. doi:10.1016/S0140-6736(15)60126-X
NLM
Mehta RL, Cerdá J, Burdmann EA, Tonelli M, García-García G, Jha V, Susantitaphong P, Rocco M, Vanholder R, Sever MS, Cruz D, Jaber B, Lameire NH, Lombardi R, Lewington A, Feehally J, Finkelstein F, Levin N, Pannu N. International Society of Nephrology's 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology [Internet]. Lancet. 2015 ; 385( 9987): 2616-2643.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/S0140-6736(15)60126-X
Vancouver
Mehta RL, Cerdá J, Burdmann EA, Tonelli M, García-García G, Jha V, Susantitaphong P, Rocco M, Vanholder R, Sever MS, Cruz D, Jaber B, Lameire NH, Lombardi R, Lewington A, Feehally J, Finkelstein F, Levin N, Pannu N. International Society of Nephrology's 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology [Internet]. Lancet. 2015 ; 385( 9987): 2616-2643.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/S0140-6736(15)60126-X

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects

Indexado em